Wendy ErlerVice President, Head Patient Advocacy at Alexion Pharmaceuticals
Wendy Erler is the Vice President of Patient Experience at Alexion Astra Zeneca, rare diseases, where she is responsible for leading the enterprise innovation model to gather and incorporate patient insights throughout the drug development and commercialization processes. She leads the Global Patient Experience function and has responsibility for driving the organization’s patient centricity strategy and leads the global patient advocacy team. Wendy has developed corporate frameworks and operating models to meaningfully embed patient insights and processes that enable patient centricity. She chairs the Alexion Ethics Advisory Board. Previously, Ms. Erler was on the executive leadership team at Wave Life Sciences where she led Patient Advocacy and Commercial. Wendy serves on the board of RARE-X and n-Lorem Advisory Committee.
Wendy graduated from Miami University and earned her MBA from St. Joseph’s University.